Protective effect and mechanism of berberine on intestinal damage induced by non-steroidal anti-inflammatory drugs

Chinese Journal of Gastroenterology

Volumn 17, Issue 8, 2012, Pages 466-470

  Wang, Jin ^a   Zhang, Shuo ^a   Lü, Bin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

Author keywords

Anti Inflammatory Agents, Non Steroidal; Berberine; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Intestinal Damage; Nitric Oxide

Indexed keywords

BERBERINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DICLOFENAC; NITRATE REDUCTASE; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINE INJURY; LOW DRUG DOSE; NONHUMAN; PROTEIN EXPRESSION; RAT; SCORING SYSTEM; SERUM; SMALL INTESTINE MUCOSA; TREATMENT OUTCOME;

EID: 84871191115     PISSN: 10087125     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1008-7125.2012.08.005     Document Type: Article

References (13)

1. Cappell M S, Schein J R. Diagnosis and treatment of non-steroidal anti-inflammatory drug-associated upper gastro-intestinal toxicity[J]. Gastroenterol Clin North Am, 2000, 29 (1): 97-124.
2. Soslow R A, Dannenberg A J, Rush D, et al. COX-2 is expressed in human pulmonary, colonic, and mammary tumors[J]. Cancer, 2000, 89 (12): 2637-2645.
3. Fries J F, Williams C A, Bloch D A, et al. Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models[J]. Am J Med, 1991, 91 (3): 213-222.
4. Smalley W E, Ray W A, Daugherty J R, et al. Nonsteroidal anti-inflammatory drugs and the incidence of hospital-izations for peptic ulcer disease in elderly persons[J]. Am J Epidemiol, 1995, 141 (6): 539-545.
5. Morris A J, Madhok R, Sturrock R D, et al. Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs[J]. Lancet, 1991, 337 (8740): 520.
6. Graham D Y, Opekun A R, Willingham F F, et al. Visible small-intestinal mucosal injury in chronic NSAID users[J]. Clin Gastroenterol Hepatol, 2005, 3 (1): 55-59.
7. 2006, 26 (11): 785-786.
8. Hsu D Z, Liu M Y. Involvement of nitric oxide in gastric protection of epinephrine in endotoxin intoxication in rats[J]. Toxicology, 2004, 204 (2-3): 203-208.
9. Whittle B J. Gastrointestinal effects of nonsteroidal anti-inflammatory drugs[J]. Fundam Clin Pharmacol, 2003, 17 (3): 301-313.
10. Tanaka A, Araki H, Komoike Y, et al. Inhibition of both COX-1 and COX-2 is required for development of gastric damage in response to nonsteroidal antiinflammatory drugs[J]. J Physiol Paris, 2001, 95 (1-6): 1681-1690.
11. 2004, 4 (1): 78.
12. 2009, 28 (9): 1127-1130.
13. 2007, 18 (4): 771-772.